Price (delayed)
$0.75
Market cap
$85.35M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.14
Enterprise value
-$46.19M
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its wholly proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome
There are no recent dividends present for DTIL.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.